Joe Lewcock
individual
About
Joe Lewcock, Ph.D., is a neuroscience and drug-discovery executive focused on neurodegenerative disease. He is Chief Scientific Officer and Head of Discovery at Denali Therapeutics, and Tenvie Therapeutics lists him as both a board director and a member of its Scientific Advisory Board. Before joining Denali in 2016, he spent nine years at Genentech helping shape its neuroscience strategy and portfolio.
Areas of interest
biotechneuroscienceneurodegenerative diseaseAlzheimer's diseaseParkinson's diseaseALSrare genetic disordersCNS drug discoveryblood-brain barrier therapeutics